Page last updated: 2024-08-26

nicotine and dianicline

nicotine has been researched along with dianicline in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Frølund, B; Jensen, AA; Krogsgaard-Larsen, P; Liljefors, T	1
Avenet, P; Bergis, OE; Besnard, F; Biton, B; Caille, D; Cohen, C; Coste, A; Curet, O; Galli, F; Gardes, A; George, P; Graham, D; Jegham, S; Leonardon, J; Lochead, AW; Oblin, A; Perrault, G; Scatton, B; Sgard, F; Soubrie, P; Voltz, C	1
Cahill, K; Lancaster, T; Stead, LF	1
Cahill, K; Fanshawe, TR; Lancaster, T; Lindson-Hawley, N; Thomas, KH	1

Reviews

3 review(s) available for nicotine and dianicline

Article	Year
Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. Journal of medicinal chemistry, 2005, Jul-28, Volume: 48, Issue:15 Topics: Allosteric Regulation; Amino Acid Sequence; Animals; Humans; Ligands; Mice; Mice, Knockout; Models, Molecular; Molecular Sequence Data; Nicotinic Agonists; Nicotinic Antagonists; Protein Conformation; Protein Subunits; Receptors, Nicotinic	2005
Nicotine receptor partial agonists for smoking cessation. The Cochrane database of systematic reviews, 2012, Apr-18, Issue:4 Topics: Alkaloids; Azepines; Azocines; Benzazepines; Bupropion; Counseling; Heterocyclic Compounds, 4 or More Rings; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline	2012
Nicotine receptor partial agonists for smoking cessation. The Cochrane database of systematic reviews, 2016, May-09, Issue:5 Topics: Alkaloids; Azepines; Azocines; Benzazepines; Bupropion; Counseling; Heterocyclic Compounds, 4 or More Rings; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline	2016

Other Studies

1 other study(ies) available for nicotine and dianicline

Article	Year
SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation. The Journal of pharmacology and experimental therapeutics, 2003, Volume: 306, Issue:1 Topics: Animals; Azepines; Behavior, Animal; Body Temperature; Brain; Cardiovascular System; Cells, Cultured; Dextroamphetamine; Discrimination Learning; Drug Interactions; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Mecamylamine; Microdialysis; Motor Activity; Nicotine; Nicotinic Agonists; Oocytes; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Self Administration; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Transfection; Xenopus laevis	2003

Article

Year

SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.

The Journal of pharmacology and experimental therapeutics, 2003, Volume: 306, Issue:1

Topics: Animals; Azepines; Behavior, Animal; Body Temperature; Brain; Cardiovascular System; Cells, Cultured; Dextroamphetamine; Discrimination Learning; Drug Interactions; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Mecamylamine; Microdialysis; Motor Activity; Nicotine; Nicotinic Agonists; Oocytes; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Self Administration; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Transfection; Xenopus laevis

2003